Cargando…

Colorectal Serrated Neoplasia: An Institutional 12-Year Review Highlights the Impact of a Screening Programme

BACKGROUND: As the malignant potential of sessile serrated lesions/polyps (SSL/Ps) and traditional serrated adenomas (TSAs) has been clearly demonstrated, it is important that serrated polyps are identified and correctly classified histologically. AIM: Our aim was to characterize the clinicopatholog...

Descripción completa

Detalles Bibliográficos
Autores principales: McCarthy, A. J., O'Reilly, S. M., Shanley, J., Geraghty, R., Ryan, E. J., Cullen, G., Sheahan, K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6381559/
https://www.ncbi.nlm.nih.gov/pubmed/30881445
http://dx.doi.org/10.1155/2019/1592306
_version_ 1783396522332782592
author McCarthy, A. J.
O'Reilly, S. M.
Shanley, J.
Geraghty, R.
Ryan, E. J.
Cullen, G.
Sheahan, K.
author_facet McCarthy, A. J.
O'Reilly, S. M.
Shanley, J.
Geraghty, R.
Ryan, E. J.
Cullen, G.
Sheahan, K.
author_sort McCarthy, A. J.
collection PubMed
description BACKGROUND: As the malignant potential of sessile serrated lesions/polyps (SSL/Ps) and traditional serrated adenomas (TSAs) has been clearly demonstrated, it is important that serrated polyps are identified and correctly classified histologically. AIM: Our aim was to characterize the clinicopathological features of a series of SSL/Ps & TSAs, to assess the accuracy of the pathological diagnosis, the incidence, and the rate of dysplasia in SSL/Ps & TSAs. METHODS: We identified all colorectal serrated polyps between 01/01/2004 and 31/05/2016, by searching the laboratory information system for all cases assigned a “serrated adenoma” SNOMED code. All available and suitable slides were reviewed by one pathologist, who was blinded to the original diagnosis and the site of the polyp. Subsequently discordant cases, SSL/Ps with dysplasia, and all TSAs were reviewed by a second pathologist. RESULTS: Over a 149-month period, 759 “serrated adenoma” polyps were identified, with 664 (from 523 patients) available for review. 41.1% were reviewed by both pathologists; 15.1% (100/664) were reclassified, with the majority being changed from SSL/P to hyperplastic polyp (HYP) (66/664; 9.9%). 80.3% of these HYPs were located in the left colon, and the majority exhibited prolapse effect. There were 520 SSL/Ps (92.2%) & 40 TSAs (7.1%). The majority of SSL/Ps were in the right colon (86.7%) and were small (64.5% <1 cm), while most TSAs were in the left colon (85.7%) and were large (73.1%≥1 cm). 6.7% of SSL/Ps exhibited dysplasia, the majority of which were large (66.7%≥1 cm). Following consensus review, 13/520 (2.5%) SSL/Ps were downgraded from SSL/P with dysplasia to SSL/P without dysplasia. Detection of SSL/Ps peaked in the most recent years reviewed (87.5% reported between 2013 and 2016, inclusive), coinciding with the introduction of “BowelScreen” (the Irish FIT-based colorectal cancer screening programme). CONCLUSIONS: Awareness of, and adherence to, diagnostic criteria is essential for accurate classification of colorectal polyps.
format Online
Article
Text
id pubmed-6381559
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-63815592019-03-17 Colorectal Serrated Neoplasia: An Institutional 12-Year Review Highlights the Impact of a Screening Programme McCarthy, A. J. O'Reilly, S. M. Shanley, J. Geraghty, R. Ryan, E. J. Cullen, G. Sheahan, K. Gastroenterol Res Pract Research Article BACKGROUND: As the malignant potential of sessile serrated lesions/polyps (SSL/Ps) and traditional serrated adenomas (TSAs) has been clearly demonstrated, it is important that serrated polyps are identified and correctly classified histologically. AIM: Our aim was to characterize the clinicopathological features of a series of SSL/Ps & TSAs, to assess the accuracy of the pathological diagnosis, the incidence, and the rate of dysplasia in SSL/Ps & TSAs. METHODS: We identified all colorectal serrated polyps between 01/01/2004 and 31/05/2016, by searching the laboratory information system for all cases assigned a “serrated adenoma” SNOMED code. All available and suitable slides were reviewed by one pathologist, who was blinded to the original diagnosis and the site of the polyp. Subsequently discordant cases, SSL/Ps with dysplasia, and all TSAs were reviewed by a second pathologist. RESULTS: Over a 149-month period, 759 “serrated adenoma” polyps were identified, with 664 (from 523 patients) available for review. 41.1% were reviewed by both pathologists; 15.1% (100/664) were reclassified, with the majority being changed from SSL/P to hyperplastic polyp (HYP) (66/664; 9.9%). 80.3% of these HYPs were located in the left colon, and the majority exhibited prolapse effect. There were 520 SSL/Ps (92.2%) & 40 TSAs (7.1%). The majority of SSL/Ps were in the right colon (86.7%) and were small (64.5% <1 cm), while most TSAs were in the left colon (85.7%) and were large (73.1%≥1 cm). 6.7% of SSL/Ps exhibited dysplasia, the majority of which were large (66.7%≥1 cm). Following consensus review, 13/520 (2.5%) SSL/Ps were downgraded from SSL/P with dysplasia to SSL/P without dysplasia. Detection of SSL/Ps peaked in the most recent years reviewed (87.5% reported between 2013 and 2016, inclusive), coinciding with the introduction of “BowelScreen” (the Irish FIT-based colorectal cancer screening programme). CONCLUSIONS: Awareness of, and adherence to, diagnostic criteria is essential for accurate classification of colorectal polyps. Hindawi 2019-02-06 /pmc/articles/PMC6381559/ /pubmed/30881445 http://dx.doi.org/10.1155/2019/1592306 Text en Copyright © 2019 A. J. McCarthy et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
McCarthy, A. J.
O'Reilly, S. M.
Shanley, J.
Geraghty, R.
Ryan, E. J.
Cullen, G.
Sheahan, K.
Colorectal Serrated Neoplasia: An Institutional 12-Year Review Highlights the Impact of a Screening Programme
title Colorectal Serrated Neoplasia: An Institutional 12-Year Review Highlights the Impact of a Screening Programme
title_full Colorectal Serrated Neoplasia: An Institutional 12-Year Review Highlights the Impact of a Screening Programme
title_fullStr Colorectal Serrated Neoplasia: An Institutional 12-Year Review Highlights the Impact of a Screening Programme
title_full_unstemmed Colorectal Serrated Neoplasia: An Institutional 12-Year Review Highlights the Impact of a Screening Programme
title_short Colorectal Serrated Neoplasia: An Institutional 12-Year Review Highlights the Impact of a Screening Programme
title_sort colorectal serrated neoplasia: an institutional 12-year review highlights the impact of a screening programme
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6381559/
https://www.ncbi.nlm.nih.gov/pubmed/30881445
http://dx.doi.org/10.1155/2019/1592306
work_keys_str_mv AT mccarthyaj colorectalserratedneoplasiaaninstitutional12yearreviewhighlightstheimpactofascreeningprogramme
AT oreillysm colorectalserratedneoplasiaaninstitutional12yearreviewhighlightstheimpactofascreeningprogramme
AT shanleyj colorectalserratedneoplasiaaninstitutional12yearreviewhighlightstheimpactofascreeningprogramme
AT geraghtyr colorectalserratedneoplasiaaninstitutional12yearreviewhighlightstheimpactofascreeningprogramme
AT ryanej colorectalserratedneoplasiaaninstitutional12yearreviewhighlightstheimpactofascreeningprogramme
AT culleng colorectalserratedneoplasiaaninstitutional12yearreviewhighlightstheimpactofascreeningprogramme
AT sheahank colorectalserratedneoplasiaaninstitutional12yearreviewhighlightstheimpactofascreeningprogramme